AngioDynamics Seen Rallying 92.2% to $19.33 Mean Price Target
AngioDynamics shares closed the last session at $10.06, while a mean analyst price target of $19.33 implies a 92.2% upside, with forecasts ranging from $16.00 to $24.00 and a standard deviation of $4.16. The Zacks Consensus Estimate for current-year EPS has climbed 3.6% over the past month, earning the stock a Zacks Rank #1.
1. Analyst Price Targets and Upside
AngioDynamics closed at $10.06 in the most recent session, with three short-term analyst price targets ranging from $16.00 to $24.00. The mean target of $19.33 signals a potential 92.2% gain, while the 59.1% to 138.6% range highlights varied bullish views.
2. Standard Deviation Reflects Analyst Agreement
The standard deviation of $4.16 on the price targets suggests moderate consensus among analysts about the magnitude of the stock’s potential gain. A tighter clustering of forecasts typically indicates stronger conviction, whereas wider dispersion points to uncertainty.
3. Earnings Estimate Revisions Support Outlook
Analysts have raised the Zacks Consensus Estimate for AngioDynamics’ current-year EPS by 3.6% over the past month, reflecting at least one upward revision and no downgrades. Positive earnings revisions historically correlate with short-term stock rallies.
4. Zacks Rank #1 Signals Strong Buy Sentiment
AngioDynamics holds a Zacks Rank #1 (Strong Buy), placing it among the top 5% of over 4,000 ranked stocks based on earnings‐estimate trends. This rank underscores robust analyst confidence in the company’s near-term earnings performance.